VCV000980083.2 - ClinVar

GRCh37/hg19 16p13.11-12.3(chr16:15481920-16837613)x3

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Likely pathogenic

no assertion criteria provided

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

GRCh37/hg19 16p13.11-12.3(chr16:15481920-16837613)x3

Variation ID: 980083 Accession: VCV000980083.2

Type and length

copy number gain, -

Location

Cytogenetic: 16p13.11-12.3 16: 15481920-16837613 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Feb 13, 2022	Feb 13, 2022	Mar 1, 2021

HGVS

Protein change

Other names

Canonical SPDI

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
MYH11		No evidence available	No evidence available	GRCh38 GRCh38 GRCh37	2037	3810
ABCC1		-	-	GRCh38 GRCh38 GRCh37	140	495
ABCC6		-	-	GRCh38 GRCh38 GRCh37	1470	1833
BMERB1	-	-	-	GRCh38 GRCh38 GRCh37	-	351
CEP20		-	-	GRCh38 GRCh38 GRCh37	19	375
MARF1		-	-	GRCh38 GRCh38 GRCh37	106	455
MPV17L		-	-	GRCh38 GRCh38 GRCh37	-	341
NDE1		-	-	GRCh38 GRCh38 GRCh37	186	1959
NOMO3		-	-	GRCh38 GRCh38 GRCh37	35	307

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not provided	Likely pathogenic (1)	no assertion criteria provided	Mar 1, 2021	RCV001259259.2

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (Mar 01, 2021)	no assertion criteria provided Method: clinical testing	not provided Affected status: unknown Allele origin: germline	Quest Diagnostics Nichols Institute San Juan Capistrano Accession: SCV001436228.2 First in ClinVar: Oct 07, 2020 Last updated: Feb 13, 2022	Comment: This copy number gain involves multiple genes and is a recurrent genomic imbalance. It confers susceptibility to a range of neurodevelopmental disorders including autism spectrum … (more) This copy number gain involves multiple genes and is a recurrent genomic imbalance. It confers susceptibility to a range of neurodevelopmental disorders including autism spectrum disorder, developmental delay, intellectual disability, and speech delay. Additionally, increased risk for cardiovascular disease has been noted (Allach El Khattabi et al., J Med Genet. 2018 Oct 4. Pii: jmedgenet-2018-105389. PMID: 30287593). The clinical significance of this recurrent duplication has been debated, because similar duplications are repeatedly observed in uncharacterized controls and in unaffected relatives (Ullmann R et al., Hum Mutat. 2007 Jul;28(7):674-82.PMID: 17480035; Hannes FD et al., J Med Genet. 2009 Apr;46(4):223-32. PMID: 18550696). However, the duplication is enriched patients versus controls in multiple case-control studies (Coe et al., Nat Genet. 2014 Oct;46(10):1063-71., PMID: 25217958; Girirajan et al., N Engl J Med. 2012 Oct ;367(14):1321-31., PMID: 22970919), with some exceptions (Kaminsky et al., Genet Med. 2011 Sep;13(9):777-84., PMID: 21844811). A male-biased effect on the penetrance of the neurodevelopmental phenotypes has been reported (Tropeano M et al., PLoS One. 2013 Apr 18;8(4):e61365.; PMID: 23637818). Thus, the clinical significance of this copy number variant (CNV) is likely pathogenic. Please note: because of variable phenotypic expressivity, incomplete penetrance, and occurrence in control populations, it is best interpreted as a susceptibility locus. (less)

Comment:

This copy number gain involves multiple genes and is a recurrent genomic imbalance. It confers susceptibility to a range of neurodevelopmental disorders including autism spectrum disorder, developmental delay, intellectual disability, and speech delay. Additionally, increased risk for cardiovascular disease has been noted (Allach El Khattabi et al., J Med Genet. 2018 Oct 4. Pii: jmedgenet-2018-105389. PMID: 30287593). The clinical significance of this recurrent duplication has been debated, because similar duplications are repeatedly observed in uncharacterized controls and in unaffected relatives (Ullmann R et al., Hum Mutat. 2007 Jul;28(7):674-82.PMID: 17480035; Hannes FD et al., J Med Genet. 2009 Apr;46(4):223-32. PMID: 18550696). However, the duplication is enriched patients versus controls in multiple case-control studies (Coe et al., Nat Genet. 2014 Oct;46(10):1063-71., PMID: 25217958; Girirajan et al., N Engl J Med. 2012 Oct ;367(14):1321-31., PMID: 22970919), with some exceptions (Kaminsky et al., Genet Med. 2011 Sep;13(9):777-84., PMID: 21844811). A male-biased effect on the penetrance of the neurodevelopmental phenotypes has been reported (Tropeano M et al., PLoS One. 2013 Apr 18;8(4):e61365.; PMID: 23637818). Thus, the clinical significance of this copy number variant (CNV) is likely pathogenic. Please note: because of variable phenotypic expressivity, incomplete penetrance, and occurrence in control populations, it is best interpreted as a susceptibility locus.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Mar 26, 2023

ClinVar Genomic variation as it relates to human health

GRCh37/hg19 16p13.11-12.3(chr16:15481920-16837613)x3

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...